Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aerosolized Antibiotics for VAP
NCT02478710Phase 4Terminated
- Sponsor
- Wright State University
- Start
- Jun 2015
- Primary completion
- Feb 2017
- Modality
- Cyclic Peptides, Antimicrobial Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of tobramycin, vancomycin in ventilator-associated pneumonia (VAP), sponsored by Wright State University. Started Jun 2015; status: terminated.
02
Drugs
tobramycinvancomycin
03
Conditions
ventilator-associated pneumonia (VAP)
Beyond the preview
Go deeper on NCT02478710.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02478710.